TY - JOUR
T1 - TSPO circadian pattern
T2 - a test-retest study of [11C]ER176
AU - Finn, Quentin
AU - Zanotti Fregonara, Paolo
AU - Yu, Meixiang Max
AU - Fujita, Masahiro
AU - Masdeu, Joseph C.
AU - Pascual, Belen
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2025.
PY - 2025
Y1 - 2025
N2 - Purpose: Mitochondrial translocator protein 18 kDa (TSPO), expressed by brain cells involved in immunity, has been a positron emission tomography (PET) target in numerous neurological and psychiatric studies. TSPO PET ligand binding is influenced by the single nucleotide polymorphism rs6971, dividing the population into three groups: high-affinity binders (HAB), mixed-affinity binders (MAB), and low-affinity binders (LAB). Unlike most “second generation” TSPO ligands, [11C]ER176 allows imaging of even LAB. This study examines the yet unstudied test-retest reproducibility of [11C]ER176 binding in all TSPO genotypes. Methods: Twelve healthy participants were studied. Seven had two [11C]ER176 PET scans in the same day, morning and afternoon; five of these had a third PET scan on a separate morning. Five additional controls underwent two scans on separate mornings. Metabolite-corrected arterial input function (AIF) was used to calculate total distribution volume (VT) with a two-tissue compartment model. Results: VT showed showed excellent reproducibility for scans performed at the same time of day: for AM scans, whole-brain variability, excluding an outlier, was 12.4 ± 6.0%. The intraclass correlation coefficient was excellent, at 0.92. However, VT showed a significant diurnal effect: [11C]ER176 parent SUV was higher in all subjects in AM compared to PM, while brain VT was lower in AM. HABs and MABs showed greater VT increases: whole-brain VT variability for AM versus PM was 8.5 ± 5.8% / 28.4 ± 4.5% / 28.5 ± 8.0% for LAB/MAB/HAB. Conclusion: [11C]ER176 brain VT has good reproducibility across days for scans performed in the morning. However, VT shows diurnal effects, which must be accounted for in study design.
AB - Purpose: Mitochondrial translocator protein 18 kDa (TSPO), expressed by brain cells involved in immunity, has been a positron emission tomography (PET) target in numerous neurological and psychiatric studies. TSPO PET ligand binding is influenced by the single nucleotide polymorphism rs6971, dividing the population into three groups: high-affinity binders (HAB), mixed-affinity binders (MAB), and low-affinity binders (LAB). Unlike most “second generation” TSPO ligands, [11C]ER176 allows imaging of even LAB. This study examines the yet unstudied test-retest reproducibility of [11C]ER176 binding in all TSPO genotypes. Methods: Twelve healthy participants were studied. Seven had two [11C]ER176 PET scans in the same day, morning and afternoon; five of these had a third PET scan on a separate morning. Five additional controls underwent two scans on separate mornings. Metabolite-corrected arterial input function (AIF) was used to calculate total distribution volume (VT) with a two-tissue compartment model. Results: VT showed showed excellent reproducibility for scans performed at the same time of day: for AM scans, whole-brain variability, excluding an outlier, was 12.4 ± 6.0%. The intraclass correlation coefficient was excellent, at 0.92. However, VT showed a significant diurnal effect: [11C]ER176 parent SUV was higher in all subjects in AM compared to PM, while brain VT was lower in AM. HABs and MABs showed greater VT increases: whole-brain VT variability for AM versus PM was 8.5 ± 5.8% / 28.4 ± 4.5% / 28.5 ± 8.0% for LAB/MAB/HAB. Conclusion: [11C]ER176 brain VT has good reproducibility across days for scans performed in the morning. However, VT shows diurnal effects, which must be accounted for in study design.
KW - Astrocyte
KW - Inflammation
KW - Microglia
KW - PET
KW - TSPO
KW - [C]ER176
UR - https://www.scopus.com/pages/publications/105009609503
UR - https://www.scopus.com/inward/citedby.url?scp=105009609503&partnerID=8YFLogxK
U2 - 10.1007/s00259-025-07429-2
DO - 10.1007/s00259-025-07429-2
M3 - Article
AN - SCOPUS:105009609503
SN - 1619-7070
JO - European Journal of Nuclear Medicine and Molecular Imaging
JF - European Journal of Nuclear Medicine and Molecular Imaging
ER -